Avalo Therapeutics (AVTX) Liabilities from Discontinued Operations (2018 - 2019)
Avalo Therapeutics' Liabilities from Discontinued Operations was $1.76 million in Q4 2019, down 91.7% from $21.03 million a year earlier.
Powered by 
Analysis
Avalo Therapeutics (AVTX) Liabilities from Discontinued Operations (2018 - 2019) Analysis & Trends
- In earlier years, Liabilities from Discontinued Operations was $21.03 million in FY2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Avalo Therapeutics | 651.85 Mn | 651.85 Mn | - |
API Access
Avalo Therapeutics Liabilities from Discontinued Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=AVTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-from-discontinued-operations", "ticker": "AVTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=AVTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();